Clinical and Vaccine Immunology? (CVI) ceased publication with the December 2017 issue. First launched as Clinical and Diagnostic Laboratory Immunology (CDLI) in 1994, CVI published articles that enhanced the understanding of the immune response in health and disease and after vaccination by showcasing discoveries in clinical, laboratory, and vaccine immunology. CVI was committed to advancing all aspects of vaccine research and immunization, including discovery of new vaccine antigens and vaccine design, development and evaluation of vaccines in animal models and in humans, characterization of immune responses and mechanisms of vaccine action, controlled challenge studies to assess vaccine efficacy, study of vaccine vectors, adjuvants, and immunomodulators, immune correlates of protection, and clinical trials. As of January 2018, papers in the areas of vaccine research and clinical and diagnostic immunology are published in ASM's cross-disciplinary, open access journal, mSphere?. Everything published in CVI and CDLI will continue to be available online, as noted below.mSphere’s broader audience and open access format offer an opportunity for greater impact in the field. CVI Editor in Chief Marcela Pasetti is a Senior Editor for mSphere. She will be joined by current CVI Editors Roshini Abraham, Jacqueline Achkar, Drusilla Burns, Christopher Papasian, David Pascual, Helene Rosenberg, and Patricia Wilkins, all of whom have been appointed to the mSphere Board of Editors.The Clinical and Vaccine Immunology website will remain on HighWire and all articles are freely available; full text of articles will continue to be available through PubMed Central. Permissions will continue to be obtained from CCC RightsLink via a link provided on the EC article page. mSphere searches will include CVI/ CDLI content by default.This title was published monthly, as Clinical and Diagnostic Laboratory Immunology, from 1994 to 2005 and then as Clinical and Vaccine Immunology from 2006 to 2017. In 2008 CVI became an online only journal. ISSN: 1556-679X. Previous print ISSN: 1556-6811.

臨床與疫苗免疫學?(CVI)在2017年12月停刊。CVI于1994年作為臨床和診斷實驗室免疫學(Clinical and Diagnostic Laboratory Immunology, CDLI)首次推出，發表了一些文章，通過展示在臨床、實驗室和疫苗免疫學方面的發現，增進了對健康和疾病以及接種疫苗后免疫反應的理解。CVI致力于推進疫苗研究和免疫的各個方面,包括新發現的疫苗抗原和疫苗設計、開發和評估疫苗在動物模型和人類,疫苗免疫反應的特征和機制行動,控制挑戰研究評估疫苗功效,疫苗研究向量,佐劑、免疫調制劑、免疫相關的保護,和臨床試驗。截至2018年1月，ASM的跨學科開放獲取雜志mSphere?發表了疫苗研究、臨床和診斷免疫學領域的論文。CVI和CDLI中發布的所有內容將繼續在線提供，如下所述。mSphere更廣泛的受眾和開放訪問格式為在該領域產生更大影響提供了機會。CVI總編輯Marcela Pasetti是mSphere的高級編輯。她將與現任CVI編輯羅希尼·亞伯拉罕、杰奎琳·阿克卡爾、德魯西拉·伯恩斯、克里斯托弗·帕帕斯亞、大衛·帕斯夸爾、海倫·羅森伯格和帕特麗夏·威爾金斯一起加入mSphere編輯委員會。臨床和疫苗免疫學網站將繼續在HighWire和所有文章免費提供;文章全文將繼續通過PubMed Central提供。許可將繼續從CCC RightsLink通過EC文章頁面提供的鏈接獲得。默認情況下，mSphere搜索將包含CVI/ CDLI內容。1994年至2005年，《臨床與診斷實驗室免疫學》月刊出版，2006年至2017年，《臨床與疫苗免疫學》月刊出版。2008年，CVI成為唯一的在線期刊。石頭:1556 - 679 x。前一版ISSN: 1556-6811。